The central competent authority, in conjunction with related authorities if necessary, shall strengthen the management of original Chinese medicine materials and actively develop and support the cultivation of Chinese medicinal plants.
The lease of public lands or lands owned by the state-owned enterprises to cultivate Chinese medicinal plants, which are approved by the central competent authority in conjunction with related authorities, shall be entitled to receive rewards and the guarantee of land lease period; while Article 43 of National Property Act and the local regulations regarding the lease period of the public property shall not apply to the aforementioned land lease period.
The award requirements, process, land lease period guarantee and other related matters shall be determined by the central competent authority in consultation with the central authorities in charge of relevant industries, the authority governing the public land or the land owned by state-owned enterprises and other related authorities.

The central competent authority shall consummate the regulations governing the quality control of Chinese medicine products and implement the specification, standardization and modernization of Chinese medicine products.

The competent authority shall improve the post-market monitoring of Chinese medicine products and announce the result of such measures.
The regulations governing the monitoring of the products, items, quantity and other related matters of the post-market monitoring shall be determined by the central competent authority.

The government shall assist the Chinese pharmaceutical industry in the international market promotion and thereby facilitate its development.